FeAsibility of a PReoperative, Multimodal Lifestyle InterventiOn in Patients With Breast Cancer ReceivIng Neoadjuvant Chemotherapy

Status: Recruiting
Location: See location...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The primary objective of this study is to investigate the feasibility of a multimodal prehabilitation programme consisting of MIET during neoadjuvant intravenous chemotherapy infusion, HITT and strength training during the last six weeks prior to surgery, and optimising nutritional intake throughout the total preoperative period in patients with breast cancer with respect to recruitment, adherence, dropout, safety and acceptance. The secondary objective is to provide a preliminary evaluation of participant responses to a preoperative multimodal lifestyle intervention, on cardiorespiratory fitness, muscle strength, nutritional status, and fatigue in patients with breast cancer receiving neoadjuvant chemotherapy.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Patients diagnosed with stage I-III breast cancer eligible for neoadjuvant intravenous chemotherapy at the MUMC+

• Aged ≥18 years

• Eastern Cooperative Oncology Group (ECOG) Performance Status Scale grade 0-1 (Table 1)

• Enough understanding of the Dutch language

Locations
Other Locations
Netherlands
Maastricht University Medical Center
RECRUITING
Maastricht
Contact Information
Primary
Hanneke van Dijk - Huisman, PhD
hanneke.huisman@mumc.nl
+31 43 3877146
Backup
Anouk Weemaes, MSc
anouk.weemaes@mumc.nl
+31 43 3877146
Time Frame
Start Date: 2024-05-27
Estimated Completion Date: 2025-11-01
Participants
Target number of participants: 11
Treatments
Experimental: multimodal lifestyle intervention
A group receiving a multimodal prehabilitation programme consisting of three modalities:~1. MIET during neoadjuvant intravenous chemotherapy infusion~2. HITT and strength training during the last six weeks prior to surgery~3. Optimising nutritional intake throughout the total preoperative period
Related Therapeutic Areas
Sponsors
Collaborators: Nationaal Fonds tegen Kanker
Leads: Maastricht University Medical Center

This content was sourced from clinicaltrials.gov